SEC Form 4 · accession 0001104659-18-038711
Jaguar Health, Inc. · JAGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven R. King
Officer — Executive VP and Secretary
Period of report
Jun 1, 2018
Accepted (ET)
Jun 6, 2018 · 9:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001585608
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2,F3,F4 | $2.73 | Jun 1, 2018 | A | 149,311 | A | — | Apr 12, 2028 | Common Stock | 149,311 | 149,311 | D |
Explanation of responses
- F1Granted pursuant to the Issuer's 2014 Equity Incentive Plan
- F2All share numbers and the exercise price reflect the 1-for-15 reverse stock split effected on June 1, 2018.
- F3The option grant was approved by the Issuer's board of directors on April 12, 2018, subject to the stockholders approving and effecting a reverse stock split. The Issuer's shareholders approved the reverse stock split on May 18, 2018 and effected such stock split on June 1, 2018.
- F4Vests in equal monthly installments, beginning on May 1, 2018, such that it is vested in full on the 3-year anniversary of the grant date.